Svetlana Cherepanoff Selected Research

Svetlana Cherepanoff Research Topics

4	Neoplasms (Cancer) 08/2022 - 04/2019
3	Uveal melanoma 08/2022 - 04/2019
3	Melanoma (Melanoma, Malignant) 11/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 08/2022 - 11/2021
2	Inflammation (Inflammations) 01/2021 - 05/2019
1	Monosomy 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Vision Disorders (Hemeralopia) 01/2020
1	Cicatrix (Scar) 05/2019
1	Lymphoma (Lymphomas) 05/2019
1	Blepharitis 04/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Aneurysm (Aneurysms) 09/2018
1	Epiretinal Membrane (Epiretinal Membranes) 09/2018
1	Retinal Telangiectasis 09/2018
1	Graves Ophthalmopathy 08/2018
1	Keratitis 08/2018
1	Wounds and Injuries (Trauma) 08/2018
1	Glomerulonephritis 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 08/2006

3	Eosine Yellowish-(YS) (Eosin)IBA 02/2021 - 04/2019
2	Histone Deacetylase InhibitorsIBA 11/2021 - 04/2019
2	Hematoxylin (Haematoxylon)IBA 02/2021 - 01/2021
2	LipidsIBA 12/2020 - 04/2019
2	EnzymesIBA 12/2020 - 04/2019
2	Retinaldehyde (Retinal)IBA 01/2020 - 08/2006
1	Phosphotransferases (Kinase)IBA 08/2022
1	AfatinibIBA 08/2022
1	Pharmaceutical PreparationsIBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Guanine NucleotidesIBA 11/2021
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 12/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019
1	Formaldehyde (Formol)FDA Link 04/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2019
1	ParaffinIBA 04/2019
1	Sirtuin 2IBA 04/2019
1	MercuryIBA 01/2019
1	ArgonIBA 09/2018
1	Bevacizumab (Avastin)FDA Link 09/2018
1	SofosbuvirIBA 01/2018
1	daclatasvirIBA 01/2018
1	AutoantibodiesIBA 08/2006